{"ticker": {"uuid": "561f63ea-bea0-4ff9-9798-90913c9668d6", "symbol": "LIVN", "name": "LivaNova PLC", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Medical Devices"}, "articles": [{"title": "LIVN Maintains by Mizuho -- Price Target Raised to $95.00", "summary": "Mizuho analyst Anthony Petrone maintained an Outperform rating for LivaNova (LIVN) and raised the price target to $95.00 from $90.00. This reflects confidence in the company's growth, despite GuruFocus indicating LIVN is currently overvalued with a GF Value\u2122 of $62.61 against a c", "url": "https://www.gurufocus.com/news/8960853/livn-maintains-by-mizuho-price-target-raised-to-9500", "source_name": "GuruFocus", "published_at": "2026-07-15T19:40:21", "published_display": "15 Jul 2026 19:40", "sentiment": "positive", "sentiment_pct": 64, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 96, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LivaNova PLC (LIVN) Shares Fall 4.7% -- GF Value Says Still Over", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOenpqYkFWRDJMQWtHaVBYU04ycGxwVUJMM0wyRXZPNk11dHMwaEdSdGVwTXlOZjZrN1NKdWNpZ0xUMUYzVUNoNlEyMjkyQ19ZTDVTQVRTS2ZENlZYLTM1Z3k5MWZkaEozcHJtcW56S3BSaU5NbFE3Z2UtNlF2bEtiQjRkQVNnM2pjcWpDV3Z0RjdXVnh5QXFJNWZLSWE5Wkh0dWpOU3ZOTmtYVDFDMEFSdnZsN3Y?oc=5", "source_name": "GuruFocus", "published_at": "2026-07-14T23:55:28+00:00", "published_display": "14 Jul 2026 23:55", "sentiment": "negative", "sentiment_pct": 22, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "LivaNova PLC (LIVN) Shares Fall 4.7% -- GF Value Says Still Overvalued", "summary": "LivaNova PLC (LIVN) shares fell 4.7% to $79.13, yet GuruFocus's GF Value still assesses the stock as \"Modestly Overvalued\" with an estimated intrinsic value of $62.60. Despite a current P/E ratio lower than its historical median, insider selling of $0.2 million with no buying act", "url": "https://www.gurufocus.com/news/8958859/livanova-plc-livn-shares-fall-47-gf-value-says-still-overvalued?mobile=true", "source_name": "GuruFocus", "published_at": "2026-07-14T18:43:00", "published_display": "14 Jul 2026 18:43", "sentiment": "negative", "sentiment_pct": 35, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LivaNova PLC (LIVN) hit a 52 week high, can the run continue?", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgJBVV95cUxNUkVIa1NiRmpFOFQ0aDc2Y2NUSW5fbzN0bjR3N1poTHVaX2FOakFkRTBSY3lob1RTU0tLSXYxU2dpeUc1M2dHZ25uWmxnM1VFQ3JZaEc4WFFjZHptNDFfQmRCdWZtdEc4N2NOZWxPNFNFOEczY3dmd0NOVDhzcDlZUVdZZnBGUldTZUJRTFBkMXNvbEw0OEZsR3hHZUtMYzJxWWlEU3c4b1lXVDhlaXVhZ3FTamoyYTFhMTh0ckNsQ0VZUVF3bjloUlVaTjlHeTYtWW9feTR6Ujg0bWVma2Nlb2xWVGo1elJDNF9tMzZzNE9vVmk3UjdDRVZlbjItWk14N0kxbGc3SnhJRlp3aGo4RVRSbl9CdV9fRlJpbkd0MDgtMXJBbFdHMDBmOF9WS3cwci1weGdTb2pnTlh4RWpybE1QNXZIQQ?oc=5", "source_name": "MSN", "published_at": "2026-07-14T15:45:39+00:00", "published_display": "14 Jul 2026 15:45", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LivaNova appoints Anne Liddy as chief legal officer", "summary": "LivaNova has announced the appointment of Anne Liddy as the new chief legal officer. Liddy brings experience from her previous role as global legal head for the cardiovascular, renal, and medical products group at Baxter International, and has held positions at Hillrom and Abbott", "url": "https://www.msn.com/en-us/money/careersandeducation/livanova-appoints-anne-liddy-as-chief-legal-officer/ar-AA24Uvrs?ocid=BingNewsVerp", "source_name": "MSN", "published_at": "2026-07-10T13:40:40", "published_display": "10 Jul 2026 13:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBIT forward of LivaNova Plc \u2013 SWB:LIA", "summary": "This article provides financial information for LivaNova Plc (SWB:LIA), specifically focusing on its enterprise value to EBIT forward. The content is presented within the context of TradingView's platform, offering financial data and market insights for the Stuttgart Stock Exchan", "url": "https://www.tradingview.com/symbols/SWB-LIA/financials-statistics-and-ratios/enterprise-value-ebit-fwd/", "source_name": "TradingView", "published_at": "2026-07-10T03:13:52", "published_display": "10 Jul 2026 03:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of LivaNova Plc \u2013 SWB:LIA", "summary": "This article provides financial information for LivaNova Plc (SWB:LIA), specifically focusing on its Price to Earnings Forward metric. The content, presented by TradingView, is part of a larger financial data service, indicating no specific data points but rather a static page fo", "url": "https://www.tradingview.com/symbols/SWB-LIA/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-07-10T02:39:50", "published_display": "10 Jul 2026 02:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of LivaNova PLC \u2013 NASDAQ:LIVN", "summary": "This article provides the \"Price to sales forward\" metric for LivaNova PLC (NASDAQ: LIVN) on TradingView. It indicates that the market is closed and no trades have occurred for this specific metric. The content is presented within the context of TradingView's financial analysis t", "url": "https://www.tradingview.com/symbols/NASDAQ-LIVN/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-09T07:13:52", "published_display": "09 Jul 2026 07:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LivaNova PLC balances neuromodulation growth with cardiac surgery challenges", "summary": "LivaNova PLC focuses on expanding its neuromodulation solutions for neurological disorders while maintaining its core presence in cardiac surgery devices. The company balances investments between these two areas, with neuromodulation offering higher growth potential and cardiac s", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/livanova-plc-balances-neuromodulation-growth-with-cardiac-surgery/69724813", "source_name": "AD HOC NEWS", "published_at": "2026-07-08T17:18:00", "published_display": "08 Jul 2026 17:18", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "(LIVN) as a Liquidity Pulse for Institutional Tactics", "summary": "This article provides an in-depth AI-driven analysis for Livanova Plc (NASDAQ: LIVN), highlighting strong sentiment across all horizons supporting an overweight bias. It outlines detailed institutional trading strategies, including position trading, momentum breakout, and risk he", "url": "https://news.stocktradersdaily.com/news_release/35/LIVN_as_a_Liquidity_Pulse_for_Institutional_Tactics_070826030601_1783537561.html", "source_name": "Stock Traders Daily", "published_at": "2026-07-08T15:06:00", "published_display": "08 Jul 2026 15:06", "sentiment": "positive", "sentiment_pct": 80, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of LivaNova PLC \u2013 NASDAQ:LIVN", "summary": "This article provides financial data for LivaNova PLC (NASDAQ: LIVN), specifically its price-to-book forward ratio. It is a brief financial snippet from TradingView, offering current valuation metrics for the company.", "url": "https://www.tradingview.com/symbols/NASDAQ-LIVN/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-07-07T17:39:44", "published_display": "07 Jul 2026 17:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LivaNova Stock Sinks After Key Sleep Trial Fails", "summary": "LivaNova PLC's stock is falling after its OSPREY clinical trial for the aura6000 sleep apnea device failed to achieve its primary efficacy goal, leading to the study's discontinuation. This setback eliminates a significant growth opportunity for LivaNova and concerns investors ab", "url": "https://www.tipranks.com/news/catalyst/livanova-stock-sinks-after-key-sleep-trial-fails", "source_name": "TipRanks", "published_at": "2026-07-07T17:39:44", "published_display": "07 Jul 2026 17:39", "sentiment": "negative", "sentiment_pct": 20, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of LivaNova PLC \u2013 NASDAQ:LIVN", "summary": "This article focuses on the enterprise value to EBITDA forward for LivaNova PLC (NASDAQ: LIVN) as presented on TradingView. It appears to be a financial data snippet from a larger platform, indicating the company's financial metrics under the \"Financials\" section. The document pr", "url": "https://www.tradingview.com/symbols/NASDAQ-LIVN/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-07-07T14:11:10", "published_display": "07 Jul 2026 14:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LivaNova PLC focuses on neuromodulation and cardiopulmonary solutions as investors track its Nasdaq-listed stock", "summary": "LivaNova PLC (LIVN) is a global medical technology company listed on Nasdaq, specializing in medical devices for cardiovascular care and neuromodulation therapy. The company's long-term growth is driven by demand for life-saving procedures and chronic disease management, with a f", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/livanova-plc-focuses-on-neuromodulation-and-cardiopulmonary-solutions-as/69713591", "source_name": "AD HOC NEWS", "published_at": "2026-07-07T12:11:10", "published_display": "07 Jul 2026 12:11", "sentiment": "positive", "sentiment_pct": 66, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of LivaNova Plc \u2013 LSX:A14156", "summary": "This article displays the \"Price to sales forward\" metric for LivaNova Plc (LSX:A14156) on TradingView. It appears to be a financial data snippet from the platform, showing basic company information and navigation to various financial tools and community features.", "url": "https://www.tradingview.com/symbols/LSX-A14156/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-07T08:11:10", "published_display": "07 Jul 2026 08:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How LivaNova\u2019s Broad Russell Index Inclusion Will Impact LivaNova (LIVN) Investors", "summary": "LivaNova PLC (NasdaqGS:LIVN) was recently added to several Russell growth and small-cap indexes, including the Russell 2000 Growth-Defensive Index and Russell 3000 Growth Benchmark. This inclusion is expected to increase the company's visibility among institutional investors but ", "url": "https://simplywall.st/stocks/us/healthcare/nasdaq-livn/livanova/news/how-livanovas-broad-russell-index-inclusion-will-impact-liva", "source_name": "Simply Wall Street", "published_at": "2026-07-07T05:10:54", "published_display": "07 Jul 2026 05:10", "sentiment": "positive", "sentiment_pct": 64, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBIT forward of LivaNova Plc \u2013 DUS:LIA", "summary": "This article provides financial information for LivaNova Plc (DUS:LIA) including its Enterprise Value to EBIT forward metric. The content appears to be a stub or a section of a larger financial data page from TradingView, displaying various navigation and informational links rela", "url": "https://www.tradingview.com/symbols/DUS-LIA/financials-statistics-and-ratios/enterprise-value-ebit-fwd/", "source_name": "TradingView", "published_at": "2026-07-06T23:41:08", "published_display": "06 Jul 2026 23:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LivaNova stock hits 52-week high at 84.3 USD", "summary": "LivaNova PLC's stock reached a new 52-week high of $84.30, demonstrating an 81% total return over the past year. The company also announced promising data from its PolySync algorithm for sleep apnea and made several strategic leadership appointments and board additions. Investing", "url": "https://www.investing.com/news/company-news/livanova-stock-hits-52week-high-at-843-usd-93CH-4776747", "source_name": "Investing.com", "published_at": "2026-07-06T13:40:39", "published_display": "06 Jul 2026 13:40", "sentiment": "positive", "sentiment_pct": 75, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LivaNova (LIVN) Joins Russell Indexes, Is The Stock Fully Priced?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-03T07:00:00+00:00", "published_display": "03 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LivaNova Shares Positive 12-Month Results From Obstructive Sleep Apnea Study", "summary": "LivaNova Plc announced positive 12-month results from its OSPREY randomized controlled trial (RCT) for the aura6000 System, demonstrating the safety and efficacy of proximal hypoglossal nerve stimulation (pHGNS) in treating moderate to severe obstructive sleep apnea (OSA). The st", "url": "https://www.mpo-mag.com/breaking-news/livanova-shares-positive-12-month-results-from-obstructive-sleep-apnea-study/", "source_name": "Medical Product Outsourcing", "published_at": "2026-06-30T16:10:38", "published_display": "30 Jun 2026 16:10", "sentiment": "positive", "sentiment_pct": 91, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Livanova stock initiated at Hold by Freedom Capital on growth outlook", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxPVFVuWncxQ1FXYTVlc1FZREtiTjhzNXJTNkdhbWlzT2lVNC1GNTZmZjZqTi04d29Wb2ZCN1lzUHRUSFA5S0tzTzNIVldaajlBQm8wcWgyZ0hXci1fRGE5OTlrVGxiR0o5T3l0MC1XNUozdkRHc1hhYWMtbFdBaU1QVkhVb2ZiWGJNakJXWEhHWkkzNTMydmxjaGdoSzdrOXl0c2lyQTh4MUVXSm84bmFoMVBnalhvY0tVVTAtQkZ5TUVkZ1FOb0xYbw?oc=5", "source_name": "Investing.com", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LivaNova PLC(NasdaqGS: LIVN) added to Russell Small Cap Comp Growth Benchmark", "summary": "LivaNova PLC (NasdaqGS: LIVN), a medical technology company specializing in cardiopulmonary and neuromodulation products, has been added to the Russell Small Cap Comp Growth Benchmark. This inclusion was formalized on June 29, 2026, alongside its addition to several other Russell", "url": "https://www.marketscreener.com/news/livanova-plc-nasdaqgs-livn-added-to-russell-small-cap-comp-growth-benchmark-ce7f5fdfdd80ff24", "source_name": "www.marketscreener.com", "published_at": "2026-06-29T21:09:13", "published_display": "29 Jun 2026 21:09", "sentiment": "positive", "sentiment_pct": 69, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LivaNova PLC(NasdaqGS: LIVN) added to Russell 2000 Growth Benchmark", "summary": "LivaNova PLC (NasdaqGS: LIVN), a medical technology company, has been added to the Russell 2000 Growth Benchmark. The company designs, develops, manufactures, markets, and sells products and therapies across its Cardiopulmonary and Neuromodulation segments. This inclusion highlig", "url": "https://www.marketscreener.com/news/livanova-plc-nasdaqgs-livn-added-to-russell-2000-growth-benchmark-ce7f5fdede8ef326", "source_name": "www.marketscreener.com", "published_at": "2026-06-29T10:43:36", "published_display": "29 Jun 2026 10:43", "sentiment": "positive", "sentiment_pct": 73, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LivaNova PLC(NasdaqGS: LIVN) added to Russell 3000 Growth Benchmark", "summary": "LivaNova PLC (NasdaqGS: LIVN) was added to the Russell 3000 Growth Benchmark on June 28, 2026. The company is a medical technology firm specializing in cardiopulmonary and neuromodulation products and therapies. LivaNova has also been added to other Russell benchmarks, including ", "url": "https://www.marketscreener.com/news/livanova-plc-nasdaqgs-livn-added-to-russell-3000-growth-benchmark-ce7f5fdcde8af021", "source_name": "www.marketscreener.com", "published_at": "2026-06-29T04:09:22", "published_display": "29 Jun 2026 04:09", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "(LIVN) Risk Channels and Responsive Allocation", "summary": "This article analyzes Livanova Plc (LIVN) using AI models, identifying strong sentiment across all horizons supporting an overweight bias. It provides institutional trading strategies, including position trading, momentum breakout, and risk hedging, along with multi-timeframe sig", "url": "https://news.stocktradersdaily.com/news_release/39/LIVN_Risk_Channels_and_Responsive_Allocation_062726015802_1782583082.html", "source_name": "Stock Traders Daily", "published_at": "2026-06-27T14:10:03", "published_display": "27 Jun 2026 14:10", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Livanova PLC Shs Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh", "summary": "This page provides financial actuals and estimates for Livanova PLC Shs Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh (L2IV34) traded on BMFBOVESPA. Users can explore reported financial data and analyst estimates for income statements, balance sheets, cash flow statement", "url": "https://www.tradingview.com/symbols/BMFBOVESPA-L2IV34/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-27T05:39:10", "published_display": "27 Jun 2026 05:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LivaNova Plc Actuals & Estimates (NASDAQ:LIVN)", "summary": "This article provides an overview of LivaNova PLC (NASDAQ: LIVN) stock, including its current price, performance, and analyst forecasts. It details financial actuals and estimates for the company's income statement, balance sheet, and cash flow, alongside answers to frequently as", "url": "https://www.tradingview.com/symbols/NASDAQ-LIVN/forecast-actuals-and-estimates/?category=cash_flow", "source_name": "TradingView", "published_at": "2026-06-26T20:39:10", "published_display": "26 Jun 2026 20:39", "sentiment": "positive", "sentiment_pct": 67, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LIVN Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a forecast for LivaNova PLC (LIVN) stock, including analyst price targets, historical stock performance, and expected earnings and revenue. It details the current stock price, market capitalization, and key financial metrics, while also addressing frequently", "url": "https://www.tradingview.com/symbols/NASDAQ-LIVN/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-26T13:43:37", "published_display": "26 Jun 2026 13:43", "sentiment": "positive", "sentiment_pct": 77, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LivaNova stock hits 52-week high at 81.08 USD By Investing.com", "summary": "LivaNova PLC's stock reached a new 52-week high of $81.08, reflecting a 74% increase over the past year. The company's recent Q1 2026 earnings surpassed analyst expectations, and it has announced strategic leadership changes. InvestingPro analysis suggests the stock, currently tr", "url": "https://za.investing.com/news/stock-market-news/livanova-stock-hits-52week-high-at-8108-usd-93CH-4344242", "source_name": "Investing.com South Africa", "published_at": "2026-06-26T12:39:10", "published_display": "26 Jun 2026 12:39", "sentiment": "positive", "sentiment_pct": 86, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LIA Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a forecast for LivaNova Plc (LIA) stock, including analyst price targets, ratings, and financial data. It details the company's past earnings and revenue, future estimates, and historical stock performance. The article also answers frequently asked questions", "url": "https://www.tradingview.com/symbols/FWB-LIA/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-26T07:10:41", "published_display": "26 Jun 2026 07:10", "sentiment": "positive", "sentiment_pct": 64, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How New OSA PolySync Data Could Shape LivaNova\u2019s (LIVN) Neuromodulation Investment Narrative", "summary": "LivaNova (LIVN) recently presented new clinical data for its PolySync programming algorithm, showing an 84.5% response rate in moderate to severe Obstructive Sleep Apnea patients. This data reinforces the company's neuromodulation platform and its investment in next-generation OS", "url": "https://www.sahmcapital.com/news/content/how-new-osa-polysync-data-could-shape-livanovas-livn-neuromodulation-investment-narrative-2026-06-26", "source_name": "Sahm", "published_at": "2026-06-26T02:09:13", "published_display": "26 Jun 2026 02:09", "sentiment": "positive", "sentiment_pct": 67, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Press Release: LivaNova to Announce Second-Quarter 2026 Results", "summary": "LivaNova (NASDAQ: LIVN) is scheduled to announce its second-quarter 2026 financial results after the market closes on Tuesday, August 4, 2026. The company will host a conference call and webcast on Wednesday, August 5, 2026, at 9:00 a.m. EDT to discuss these results.", "url": "https://www.moomoo.com/news/post/71969240/press-release-livanova-to-announce-second-quarter-2026-results?futusource=news_newspage_recommend", "source_name": "Moomoo", "published_at": "2026-06-25T00:09:49", "published_display": "25 Jun 2026 00:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LivaNova to Announce Second-Quarter 2026 Results", "summary": "LivaNova PLC (Nasdaq: LIVN) will host a conference call on Wednesday, August 5, 2026, at 1 p.m. London time (8 a.m. Eastern Daylight Time) to discuss its second-quarter 2026 financial results. The company plans to release its results prior to the call, which will be accessible vi", "url": "https://www.businesswire.com/news/home/20260624069083/en/LivaNova-to-Announce-Second-Quarter-2026-Results", "source_name": "Business Wire", "published_at": "2026-06-24T12:40:10", "published_display": "24 Jun 2026 12:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LivaNova Reports Improved OSA Outcomes With PolySync Programming", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/livanova-reports-improved-osa-outcomes-141400954.html", "source_name": "Zacks", "published_at": "2026-06-17T14:14:00+00:00", "published_display": "17 Jun 2026 14:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LivaNova's PolySync Algorithm Supports Improvement in Sleep Apnea Treatment Response Rate", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/livanova-apos-polysync-algorithm-supports-160849955.html", "source_name": "MT Newswires", "published_at": "2026-06-16T16:08:49+00:00", "published_display": "16 Jun 2026 16:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LivaNova Demonstrates 84.5% Cumulative Response Rate with PolySync Programming in OSPREY Study for Obstructive Sleep Apnea", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/livanova-demonstrates-84-5-cumulative-145700815.html", "source_name": "Business Wire", "published_at": "2026-06-16T14:57:00+00:00", "published_display": "16 Jun 2026 14:57", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAJBVV95cUxQLWl0NWl5MFJhUXFSN0pzSW1sVzJVb21XVml0X0doQnd5eDVUQmVqeFZWSmNmdlZaV2pfbFk3UEl3RXlqZ05pckozR0dnNHNEUlpTa2FPYWc1Z3Q0Y2tXYTljZUlQRkVZNzY2Sl9yRksyUDJkNVQzSTBuLW9uMnI5bzBfTTJGdDUzd25DN3dDSmhwWnpGVXZRVVM2Uy1zMnp4STZ1RGdZZkRpZ21Pb2xtWjRSTk1kc2JrT28wTG81NDV1M2tWaVdrOXBQdVZSTExiTVEzMXpqRnJWWi0xcEdMYVFILXZXbXZVZl9GRm12aTl5OGk4X1dSVjVyU2FIVFpubk1YNm5fQll0MVZqRTZpTA?oc=5", "source_name": "StockStory", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "LivaNova (LIVN) Stock Valuation Check After Strong Recent Shareholder Returns", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxPWjF3OWZaa0NXN3IxdU04QnVZQ2c1THRrczRrNTFSQUx4YXE4aXlqM1NVMHJkTVB5QVRlVDM1QktiMHZkRUNVNVFhM1FVYjFYa2ZCUThTZEVocExvQnB3N2xsZGpUYXdkZXB5ejZDb3djbkgtOEJ1NmlwUUhZT1VuSFV4WUFtcE1aWXBBSURZVHRVQlg3ZDYta0hnNlR4SG95TGc?oc=5", "source_name": "Market source", "published_at": "2026-06-12T07:00:00+00:00", "published_display": "12 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Jette Nygaard-Andersen Joins LivaNova Board as a New Director", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/jette-nygaard-andersen-joins-livanova-174400286.html", "source_name": "Business Wire", "published_at": "2026-06-11T17:44:00+00:00", "published_display": "11 Jun 2026 17:44", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LivaNova Stock: My Targets Hold, Maintaining My Rating For 2H26 (NASDAQ:LIVN)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxQMW40ckR6Y0Zuc1BIQnV4UTAwTGdwemNmY3pDSlRkalVfZV9tVTBVQUxKY0VhV3d3LUl5YnQyOTdnX2NZLTZoSklydG50WXlxUkNsLW5wM2F0bGt0ekNMYWZJTzBLVDYzUURRb2Y2bXRCemdzR3E0ZmkxeWRZcGljN1Q2eGhKX1E4T2E3bTFZSngxQjNfZEFXNWVtOUlTa3c3cmJ0QQ?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-06-10T07:00:00+00:00", "published_display": "10 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "LivaNova (LIVN) Upgraded to Buy: Here's What You Should Know", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/livanova-livn-upgraded-buy-heres-160006292.html", "source_name": "Zacks", "published_at": "2026-05-11T16:00:06+00:00", "published_display": "11 May 2026 16:00", "sentiment": "positive", "sentiment_pct": 76, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why LivaNova (LIVN) Is Up 18.0% After Boosting 2026 Outlook And Winning Aura6000 FDA Approval", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxPSHRGX3hXUElLelhBcVQ4UkZCNk5XallzbGw5dkJfVktRTmVtamw5V2xwU3dQVUhtc2tmVllPLXlOVkx2VWgta3F5RTd3bVlyZlRaS3RobHlac05rX0RKVl9pbXhyX3l1UzU5WEt1MzlsV2lQYjFIWXhaN3drRlo1Nm9MZEs3RWNyejlkLU16RldyaDlFYkE?oc=5", "source_name": "Market source", "published_at": "2026-05-09T07:00:00+00:00", "published_display": "09 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LivaNova (LIVN) Profit Return And 33.8x P E Test Bullish Narratives", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LivaNova Q1 2026 slides: double-digit growth drives guidance raise", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxNVG9BV0ZMeXZRQllKa3dSby1oZVNHN2NfcnVER2o4QWlISVBGbGNIVUc1RXdPVk9BaTRfQWFLR2JjdC1NTzVOMk9odXgxamhQcHlNZmVmTVItR3JqN1dtRkpXMHJEQnRjVFpydW00UTZMZ1JtYzZqVHR1U2tsMlkwRUVoUXVBY0llNVpleTl3Y2RrNTcxbEtXVHA1cWdMbzFUT3gzVVY1ajZMOGsxYm5ySGNUODNtQWF4SXZoNzh3?oc=5", "source_name": "Investing.com", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LivaNova PLC Q1 2026 Earnings Call Summary", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxPUkVRSzRoVG1Xb2pUcTRfXzFWN29TeWVvM1hIQlRqMFpVQkh3V3pHb0s4S280RE5pLVRGUDg5NmtBbEJrMnRObE5hZWxCLUtvSjdLMmhzSVVXM01rc2pCSEFuWndKMm1JR2xsbkdTUG9kZzFsVG1ocGc2OWZJM0NteDFtZzZkM1hsQ1k3VXVGTHZqVlV3cW9jRWxxSXJ2SHc?oc=5", "source_name": "Market source", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LivaNova (LIVN) Q1 Earnings and Revenues Surpass Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxNTlpqdTZWTHFVQXdZQjBXRGU2Z21ZTTR3cEFfV0RiNkhaeDJGOTUzcUhzdnNPbjBhbjVzWlFXZnMxZURXamhHRF93RHU0TXl2dVZ5a3RKTUhndnFTaDl6THZFZk1uTXIwWmx3ZFBPR0VRMzhXZkw0UTB3Vjh5OFd0MzJWRG1ueG45ZGV2WTRuVWxlZkF0bVRoSFFaWnJwOE1p?oc=5", "source_name": "Market source", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LIVANOVA ($LIVN) Releases Q1 2026 Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxNUXFZVDd0SF9wTFprNjV4TDdNczhKeER2cGU4WTY4cE55VWllWDdNazBjU2NONzVuaFkzc1VkYXdFS19EdEYyVDJpTC01akhkTEFqRFE1MUpHUld1MkEzZ21RQkVvTlhaZVFHS3lhdXEwZ0xMNmxrenZOT1ZCVVdMTVlVNHhuMzl0?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "LivaNova (LIVN) Announces FDA Approval of aura6000 System for Obstructive Sleep Apnea", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxONGdvZUgyeXNFVzB1cTc5UzI4V08xcXQ3cFkxUG94dUd0WkFNWjhYWWZxajkzYVdsOEFSYnJ1NTZKS3FEcjZvZ3JjTlRRZVdaSlV1NFpTZGxReFQzNUZMeWhOVEdyLTNWbHNtM0RlSWVYWE9FNmRQWkhyY2VicnBRVHowRVFGZzBzUHBheXhmbHNJLXk4Rk9LM0U4OG1wUDdKbkoxOTk3NFc?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "LivaNova\u2019s Aura6000 FDA Win Reshapes Obstructive Sleep Apnea Opportunity", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxONi1zMVFMalFQS2hmeGFiS1R6Mk1iOEhaMnBNSXBoRnJBbXZXWHdCZDBINE44UEJnQ2Vtekh6WVRIYmRuTGJobGZhQTFsZFROVnhIZjlvOExUVjJmNVJFUy1ueFQydVQ0OHctSHJXek11MXdDcmdpZ2daTUdRZEVHR1VjTU9rV29waU9ORDkxTUtRTzZmNVB6RUdwRGt6OXdWcUNrWEw1dFBJNG82U3NIYTRqSlVSSFRBb1BocnFvcVdDMjlmZ0Jv0gHMAUFVX3lxTE9nTVgtSXBjblEzQW5EYjZBeGFfRERjd3JNNTdCUEduN1pCZEYtYWZZRzI2bzFidlU1OVoxZVRyTXdnNlRXQmZiZUNPQzY3NjJPWWpfTExsUHNKbG5MaXlJQnRjMFdjVkM2SEFicE12UXJDdkRmZHMzMjFfUG1GVENMZVhPNE9MWVRXYTRpdkdkZ0VtazBZOGdLb1I5TkxseFhBcy12RWtWdXdBSHRUcjNEVFh2NzkwU2VnZkQxRTBlQ3hVMkcwUEFoby1UXw?oc=5", "source_name": "simplywall.st", "published_at": "2026-03-21T07:00:00+00:00", "published_display": "21 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LivaNova wins FDA Approval for sleep apnea treatment device", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxQXzVkOTAteTBCWF9lUktZTUctSFZlbnJ1ZXZZQXJBN0Fnc0NUaDg0YTJURnJlRVE4a0ZSMmNPejBGWmk1RjFkM0U3RTJOcGZDNUR2Tk9QSE5qNDI4VjF0WHF0X0lqekdQVjB6b1RpQ2lTQlZWd1NfQy1sZkx6RHRfRE1Lb1lFVzRiT3hGVG90UDV1ZDdpWFpqYTducG9nQQ?oc=5", "source_name": "Medical Economics", "published_at": "2026-03-19T07:00:00+00:00", "published_display": "19 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdFRrRlJvM3J3cGJnVEJ6ZndqMnQxWkE4Wm8zTGtPTVc0OTlLN1pwNXIyclNJMFZkcG5qQTRTWThmNm9WN0hKYXBja3N3Y20zSlkxc2JaQlpYTnAyWnpvUVBvR1JWNmVxZGhSYVlYQklMd01GeFBVNGJWOFBWYUkwYmRrM2xrSktiQWpfTkZtNG1HWThNT0tqLUpYek5qcnFWMGE0QV9CaElrMUpfTEhnOC1pS2t1bkE2VVJHdEhWdEtoX2xKNE1MWk1OSlBSNTVZVU83WEpnb3E4aURwQ3ZyZUFDbndpTTZEa0lZRTJvU2VuTDhreXdCQ25iV3Y4YWxENm1xYQ?oc=5", "source_name": "StockStory", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNMzBPcXU1cnZKekZnaGlNVk05ZWFTWThNOS0tTlpvQjdaLVZIWlVXUk50NnVoQ0pPWWJpZUpWcVJyVDJMd2RJREVDbEEzTlU5UGhBbWtxWVEyVkdaMTVuNXZpaWFMNTZUQ2d0OW9Rc29kalJRY21naWlHZDBLS3RuZV9wdTdIUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look At LivaNova (LIVN) Valuation After Earnings Show Growth Guidance And A Swing To Net Loss", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxQeXRtV2pzbkM5OE1IbUU3RjdUVXFWNl9qWEo1SGZWMHU5emJ3TXBCckJwYTBHNG8yTUNrREVQMS00Q2Vqbk1uM0d3aHlYb2dFQmRjblZFYnBwRllDelQ3UkEzSTlUcUVINV9NanFmR09keXRuSURvQ2MxUExZLWhfSjB4X2NmSXpLclpr?oc=5", "source_name": "Market source", "published_at": "2026-03-03T08:00:00+00:00", "published_display": "03 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "LIVN Maintains by Mizuho -- Price Target Raised to $95.00", "summary": "Mizuho analyst Anthony Petrone maintained an Outperform rating for LivaNova (LIVN) and raised the price target to $95.00 from $90.00. This reflects confidence in the company's growth, despite GuruFocus indicating LIVN is currently overvalued with a GF Value\u2122 of $62.61 against a c", "url": "https://www.gurufocus.com/news/8960853/livn-maintains-by-mizuho-price-target-raised-to-9500", "source_name": "GuruFocus", "published_at": "2026-07-15T19:40:21", "published_display": "15 Jul 2026 19:40", "sentiment": "positive", "sentiment_pct": 64, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 96, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LivaNova PLC (LIVN) Shares Fall 4.7% -- GF Value Says Still Over", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOenpqYkFWRDJMQWtHaVBYU04ycGxwVUJMM0wyRXZPNk11dHMwaEdSdGVwTXlOZjZrN1NKdWNpZ0xUMUYzVUNoNlEyMjkyQ19ZTDVTQVRTS2ZENlZYLTM1Z3k5MWZkaEozcHJtcW56S3BSaU5NbFE3Z2UtNlF2bEtiQjRkQVNnM2pjcWpDV3Z0RjdXVnh5QXFJNWZLSWE5Wkh0dWpOU3ZOTmtYVDFDMEFSdnZsN3Y?oc=5", "source_name": "GuruFocus", "published_at": "2026-07-14T23:55:28+00:00", "published_display": "14 Jul 2026 23:55", "sentiment": "negative", "sentiment_pct": 22, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LivaNova PLC (LIVN) Shares Fall 4.7% -- GF Value Says Still Overvalued", "summary": "LivaNova PLC (LIVN) shares fell 4.7% to $79.13, yet GuruFocus's GF Value still assesses the stock as \"Modestly Overvalued\" with an estimated intrinsic value of $62.60. Despite a current P/E ratio lower than its historical median, insider selling of $0.2 million with no buying act", "url": "https://www.gurufocus.com/news/8958859/livanova-plc-livn-shares-fall-47-gf-value-says-still-overvalued?mobile=true", "source_name": "GuruFocus", "published_at": "2026-07-14T18:43:00", "published_display": "14 Jul 2026 18:43", "sentiment": "negative", "sentiment_pct": 35, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LivaNova PLC (LIVN) hit a 52 week high, can the run continue?", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgJBVV95cUxNUkVIa1NiRmpFOFQ0aDc2Y2NUSW5fbzN0bjR3N1poTHVaX2FOakFkRTBSY3lob1RTU0tLSXYxU2dpeUc1M2dHZ25uWmxnM1VFQ3JZaEc4WFFjZHptNDFfQmRCdWZtdEc4N2NOZWxPNFNFOEczY3dmd0NOVDhzcDlZUVdZZnBGUldTZUJRTFBkMXNvbEw0OEZsR3hHZUtMYzJxWWlEU3c4b1lXVDhlaXVhZ3FTamoyYTFhMTh0ckNsQ0VZUVF3bjloUlVaTjlHeTYtWW9feTR6Ujg0bWVma2Nlb2xWVGo1elJDNF9tMzZzNE9vVmk3UjdDRVZlbjItWk14N0kxbGc3SnhJRlp3aGo4RVRSbl9CdV9fRlJpbkd0MDgtMXJBbFdHMDBmOF9WS3cwci1weGdTb2pnTlh4RWpybE1QNXZIQQ?oc=5", "source_name": "MSN", "published_at": "2026-07-14T15:45:39+00:00", "published_display": "14 Jul 2026 15:45", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LivaNova appoints Anne Liddy as chief legal officer", "summary": "LivaNova has announced the appointment of Anne Liddy as the new chief legal officer. Liddy brings experience from her previous role as global legal head for the cardiovascular, renal, and medical products group at Baxter International, and has held positions at Hillrom and Abbott", "url": "https://www.msn.com/en-us/money/careersandeducation/livanova-appoints-anne-liddy-as-chief-legal-officer/ar-AA24Uvrs?ocid=BingNewsVerp", "source_name": "MSN", "published_at": "2026-07-10T13:40:40", "published_display": "10 Jul 2026 13:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBIT forward of LivaNova Plc \u2013 SWB:LIA", "summary": "This article provides financial information for LivaNova Plc (SWB:LIA), specifically focusing on its enterprise value to EBIT forward. The content is presented within the context of TradingView's platform, offering financial data and market insights for the Stuttgart Stock Exchan", "url": "https://www.tradingview.com/symbols/SWB-LIA/financials-statistics-and-ratios/enterprise-value-ebit-fwd/", "source_name": "TradingView", "published_at": "2026-07-10T03:13:52", "published_display": "10 Jul 2026 03:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of LivaNova Plc \u2013 SWB:LIA", "summary": "This article provides financial information for LivaNova Plc (SWB:LIA), specifically focusing on its Price to Earnings Forward metric. The content, presented by TradingView, is part of a larger financial data service, indicating no specific data points but rather a static page fo", "url": "https://www.tradingview.com/symbols/SWB-LIA/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-07-10T02:39:50", "published_display": "10 Jul 2026 02:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of LivaNova PLC \u2013 NASDAQ:LIVN", "summary": "This article provides the \"Price to sales forward\" metric for LivaNova PLC (NASDAQ: LIVN) on TradingView. It indicates that the market is closed and no trades have occurred for this specific metric. The content is presented within the context of TradingView's financial analysis t", "url": "https://www.tradingview.com/symbols/NASDAQ-LIVN/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-09T07:13:52", "published_display": "09 Jul 2026 07:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LivaNova PLC balances neuromodulation growth with cardiac surgery challenges", "summary": "LivaNova PLC focuses on expanding its neuromodulation solutions for neurological disorders while maintaining its core presence in cardiac surgery devices. The company balances investments between these two areas, with neuromodulation offering higher growth potential and cardiac s", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/livanova-plc-balances-neuromodulation-growth-with-cardiac-surgery/69724813", "source_name": "AD HOC NEWS", "published_at": "2026-07-08T17:18:00", "published_display": "08 Jul 2026 17:18", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "(LIVN) as a Liquidity Pulse for Institutional Tactics", "summary": "This article provides an in-depth AI-driven analysis for Livanova Plc (NASDAQ: LIVN), highlighting strong sentiment across all horizons supporting an overweight bias. It outlines detailed institutional trading strategies, including position trading, momentum breakout, and risk he", "url": "https://news.stocktradersdaily.com/news_release/35/LIVN_as_a_Liquidity_Pulse_for_Institutional_Tactics_070826030601_1783537561.html", "source_name": "Stock Traders Daily", "published_at": "2026-07-08T15:06:00", "published_display": "08 Jul 2026 15:06", "sentiment": "positive", "sentiment_pct": 80, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of LivaNova PLC \u2013 NASDAQ:LIVN", "summary": "This article provides financial data for LivaNova PLC (NASDAQ: LIVN), specifically its price-to-book forward ratio. It is a brief financial snippet from TradingView, offering current valuation metrics for the company.", "url": "https://www.tradingview.com/symbols/NASDAQ-LIVN/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-07-07T17:39:44", "published_display": "07 Jul 2026 17:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LivaNova Stock Sinks After Key Sleep Trial Fails", "summary": "LivaNova PLC's stock is falling after its OSPREY clinical trial for the aura6000 sleep apnea device failed to achieve its primary efficacy goal, leading to the study's discontinuation. This setback eliminates a significant growth opportunity for LivaNova and concerns investors ab", "url": "https://www.tipranks.com/news/catalyst/livanova-stock-sinks-after-key-sleep-trial-fails", "source_name": "TipRanks", "published_at": "2026-07-07T17:39:44", "published_display": "07 Jul 2026 17:39", "sentiment": "negative", "sentiment_pct": 20, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of LivaNova PLC \u2013 NASDAQ:LIVN", "summary": "This article focuses on the enterprise value to EBITDA forward for LivaNova PLC (NASDAQ: LIVN) as presented on TradingView. It appears to be a financial data snippet from a larger platform, indicating the company's financial metrics under the \"Financials\" section. The document pr", "url": "https://www.tradingview.com/symbols/NASDAQ-LIVN/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-07-07T14:11:10", "published_display": "07 Jul 2026 14:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LivaNova PLC focuses on neuromodulation and cardiopulmonary solutions as investors track its Nasdaq-listed stock", "summary": "LivaNova PLC (LIVN) is a global medical technology company listed on Nasdaq, specializing in medical devices for cardiovascular care and neuromodulation therapy. The company's long-term growth is driven by demand for life-saving procedures and chronic disease management, with a f", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/livanova-plc-focuses-on-neuromodulation-and-cardiopulmonary-solutions-as/69713591", "source_name": "AD HOC NEWS", "published_at": "2026-07-07T12:11:10", "published_display": "07 Jul 2026 12:11", "sentiment": "positive", "sentiment_pct": 66, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of LivaNova Plc \u2013 LSX:A14156", "summary": "This article displays the \"Price to sales forward\" metric for LivaNova Plc (LSX:A14156) on TradingView. It appears to be a financial data snippet from the platform, showing basic company information and navigation to various financial tools and community features.", "url": "https://www.tradingview.com/symbols/LSX-A14156/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-07T08:11:10", "published_display": "07 Jul 2026 08:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How LivaNova\u2019s Broad Russell Index Inclusion Will Impact LivaNova (LIVN) Investors", "summary": "LivaNova PLC (NasdaqGS:LIVN) was recently added to several Russell growth and small-cap indexes, including the Russell 2000 Growth-Defensive Index and Russell 3000 Growth Benchmark. This inclusion is expected to increase the company's visibility among institutional investors but ", "url": "https://simplywall.st/stocks/us/healthcare/nasdaq-livn/livanova/news/how-livanovas-broad-russell-index-inclusion-will-impact-liva", "source_name": "Simply Wall Street", "published_at": "2026-07-07T05:10:54", "published_display": "07 Jul 2026 05:10", "sentiment": "positive", "sentiment_pct": 64, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBIT forward of LivaNova Plc \u2013 DUS:LIA", "summary": "This article provides financial information for LivaNova Plc (DUS:LIA) including its Enterprise Value to EBIT forward metric. The content appears to be a stub or a section of a larger financial data page from TradingView, displaying various navigation and informational links rela", "url": "https://www.tradingview.com/symbols/DUS-LIA/financials-statistics-and-ratios/enterprise-value-ebit-fwd/", "source_name": "TradingView", "published_at": "2026-07-06T23:41:08", "published_display": "06 Jul 2026 23:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LivaNova stock hits 52-week high at 84.3 USD", "summary": "LivaNova PLC's stock reached a new 52-week high of $84.30, demonstrating an 81% total return over the past year. The company also announced promising data from its PolySync algorithm for sleep apnea and made several strategic leadership appointments and board additions. Investing", "url": "https://www.investing.com/news/company-news/livanova-stock-hits-52week-high-at-843-usd-93CH-4776747", "source_name": "Investing.com", "published_at": "2026-07-06T13:40:39", "published_display": "06 Jul 2026 13:40", "sentiment": "positive", "sentiment_pct": 75, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LivaNova (LIVN) Joins Russell Indexes, Is The Stock Fully Priced?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-03T07:00:00+00:00", "published_display": "03 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LivaNova Shares Positive 12-Month Results From Obstructive Sleep Apnea Study", "summary": "LivaNova Plc announced positive 12-month results from its OSPREY randomized controlled trial (RCT) for the aura6000 System, demonstrating the safety and efficacy of proximal hypoglossal nerve stimulation (pHGNS) in treating moderate to severe obstructive sleep apnea (OSA). The st", "url": "https://www.mpo-mag.com/breaking-news/livanova-shares-positive-12-month-results-from-obstructive-sleep-apnea-study/", "source_name": "Medical Product Outsourcing", "published_at": "2026-06-30T16:10:38", "published_display": "30 Jun 2026 16:10", "sentiment": "positive", "sentiment_pct": 91, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Livanova stock initiated at Hold by Freedom Capital on growth outlook", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxPVFVuWncxQ1FXYTVlc1FZREtiTjhzNXJTNkdhbWlzT2lVNC1GNTZmZjZqTi04d29Wb2ZCN1lzUHRUSFA5S0tzTzNIVldaajlBQm8wcWgyZ0hXci1fRGE5OTlrVGxiR0o5T3l0MC1XNUozdkRHc1hhYWMtbFdBaU1QVkhVb2ZiWGJNakJXWEhHWkkzNTMydmxjaGdoSzdrOXl0c2lyQTh4MUVXSm84bmFoMVBnalhvY0tVVTAtQkZ5TUVkZ1FOb0xYbw?oc=5", "source_name": "Investing.com", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LivaNova PLC(NasdaqGS: LIVN) added to Russell Small Cap Comp Growth Benchmark", "summary": "LivaNova PLC (NasdaqGS: LIVN), a medical technology company specializing in cardiopulmonary and neuromodulation products, has been added to the Russell Small Cap Comp Growth Benchmark. This inclusion was formalized on June 29, 2026, alongside its addition to several other Russell", "url": "https://www.marketscreener.com/news/livanova-plc-nasdaqgs-livn-added-to-russell-small-cap-comp-growth-benchmark-ce7f5fdfdd80ff24", "source_name": "www.marketscreener.com", "published_at": "2026-06-29T21:09:13", "published_display": "29 Jun 2026 21:09", "sentiment": "positive", "sentiment_pct": 69, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LivaNova PLC(NasdaqGS: LIVN) added to Russell 2000 Growth Benchmark", "summary": "LivaNova PLC (NasdaqGS: LIVN), a medical technology company, has been added to the Russell 2000 Growth Benchmark. The company designs, develops, manufactures, markets, and sells products and therapies across its Cardiopulmonary and Neuromodulation segments. This inclusion highlig", "url": "https://www.marketscreener.com/news/livanova-plc-nasdaqgs-livn-added-to-russell-2000-growth-benchmark-ce7f5fdede8ef326", "source_name": "www.marketscreener.com", "published_at": "2026-06-29T10:43:36", "published_display": "29 Jun 2026 10:43", "sentiment": "positive", "sentiment_pct": 73, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LivaNova PLC(NasdaqGS: LIVN) added to Russell 3000 Growth Benchmark", "summary": "LivaNova PLC (NasdaqGS: LIVN) was added to the Russell 3000 Growth Benchmark on June 28, 2026. The company is a medical technology firm specializing in cardiopulmonary and neuromodulation products and therapies. LivaNova has also been added to other Russell benchmarks, including ", "url": "https://www.marketscreener.com/news/livanova-plc-nasdaqgs-livn-added-to-russell-3000-growth-benchmark-ce7f5fdcde8af021", "source_name": "www.marketscreener.com", "published_at": "2026-06-29T04:09:22", "published_display": "29 Jun 2026 04:09", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "(LIVN) Risk Channels and Responsive Allocation", "summary": "This article analyzes Livanova Plc (LIVN) using AI models, identifying strong sentiment across all horizons supporting an overweight bias. It provides institutional trading strategies, including position trading, momentum breakout, and risk hedging, along with multi-timeframe sig", "url": "https://news.stocktradersdaily.com/news_release/39/LIVN_Risk_Channels_and_Responsive_Allocation_062726015802_1782583082.html", "source_name": "Stock Traders Daily", "published_at": "2026-06-27T14:10:03", "published_display": "27 Jun 2026 14:10", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Livanova PLC Shs Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh", "summary": "This page provides financial actuals and estimates for Livanova PLC Shs Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh (L2IV34) traded on BMFBOVESPA. Users can explore reported financial data and analyst estimates for income statements, balance sheets, cash flow statement", "url": "https://www.tradingview.com/symbols/BMFBOVESPA-L2IV34/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-27T05:39:10", "published_display": "27 Jun 2026 05:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LivaNova Plc Actuals & Estimates (NASDAQ:LIVN)", "summary": "This article provides an overview of LivaNova PLC (NASDAQ: LIVN) stock, including its current price, performance, and analyst forecasts. It details financial actuals and estimates for the company's income statement, balance sheet, and cash flow, alongside answers to frequently as", "url": "https://www.tradingview.com/symbols/NASDAQ-LIVN/forecast-actuals-and-estimates/?category=cash_flow", "source_name": "TradingView", "published_at": "2026-06-26T20:39:10", "published_display": "26 Jun 2026 20:39", "sentiment": "positive", "sentiment_pct": 67, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LIVN Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a forecast for LivaNova PLC (LIVN) stock, including analyst price targets, historical stock performance, and expected earnings and revenue. It details the current stock price, market capitalization, and key financial metrics, while also addressing frequently", "url": "https://www.tradingview.com/symbols/NASDAQ-LIVN/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-26T13:43:37", "published_display": "26 Jun 2026 13:43", "sentiment": "positive", "sentiment_pct": 77, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LivaNova stock hits 52-week high at 81.08 USD By Investing.com", "summary": "LivaNova PLC's stock reached a new 52-week high of $81.08, reflecting a 74% increase over the past year. The company's recent Q1 2026 earnings surpassed analyst expectations, and it has announced strategic leadership changes. InvestingPro analysis suggests the stock, currently tr", "url": "https://za.investing.com/news/stock-market-news/livanova-stock-hits-52week-high-at-8108-usd-93CH-4344242", "source_name": "Investing.com South Africa", "published_at": "2026-06-26T12:39:10", "published_display": "26 Jun 2026 12:39", "sentiment": "positive", "sentiment_pct": 86, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LIA Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a forecast for LivaNova Plc (LIA) stock, including analyst price targets, ratings, and financial data. It details the company's past earnings and revenue, future estimates, and historical stock performance. The article also answers frequently asked questions", "url": "https://www.tradingview.com/symbols/FWB-LIA/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-26T07:10:41", "published_display": "26 Jun 2026 07:10", "sentiment": "positive", "sentiment_pct": 64, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How New OSA PolySync Data Could Shape LivaNova\u2019s (LIVN) Neuromodulation Investment Narrative", "summary": "LivaNova (LIVN) recently presented new clinical data for its PolySync programming algorithm, showing an 84.5% response rate in moderate to severe Obstructive Sleep Apnea patients. This data reinforces the company's neuromodulation platform and its investment in next-generation OS", "url": "https://www.sahmcapital.com/news/content/how-new-osa-polysync-data-could-shape-livanovas-livn-neuromodulation-investment-narrative-2026-06-26", "source_name": "Sahm", "published_at": "2026-06-26T02:09:13", "published_display": "26 Jun 2026 02:09", "sentiment": "positive", "sentiment_pct": 67, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Press Release: LivaNova to Announce Second-Quarter 2026 Results", "summary": "LivaNova (NASDAQ: LIVN) is scheduled to announce its second-quarter 2026 financial results after the market closes on Tuesday, August 4, 2026. The company will host a conference call and webcast on Wednesday, August 5, 2026, at 9:00 a.m. EDT to discuss these results.", "url": "https://www.moomoo.com/news/post/71969240/press-release-livanova-to-announce-second-quarter-2026-results?futusource=news_newspage_recommend", "source_name": "Moomoo", "published_at": "2026-06-25T00:09:49", "published_display": "25 Jun 2026 00:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LivaNova to Announce Second-Quarter 2026 Results", "summary": "LivaNova PLC (Nasdaq: LIVN) will host a conference call on Wednesday, August 5, 2026, at 1 p.m. London time (8 a.m. Eastern Daylight Time) to discuss its second-quarter 2026 financial results. The company plans to release its results prior to the call, which will be accessible vi", "url": "https://www.businesswire.com/news/home/20260624069083/en/LivaNova-to-Announce-Second-Quarter-2026-Results", "source_name": "Business Wire", "published_at": "2026-06-24T12:40:10", "published_display": "24 Jun 2026 12:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LivaNova Reports Improved OSA Outcomes With PolySync Programming", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/livanova-reports-improved-osa-outcomes-141400954.html", "source_name": "Zacks", "published_at": "2026-06-17T14:14:00+00:00", "published_display": "17 Jun 2026 14:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LivaNova's PolySync Algorithm Supports Improvement in Sleep Apnea Treatment Response Rate", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/livanova-apos-polysync-algorithm-supports-160849955.html", "source_name": "MT Newswires", "published_at": "2026-06-16T16:08:49+00:00", "published_display": "16 Jun 2026 16:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LivaNova Demonstrates 84.5% Cumulative Response Rate with PolySync Programming in OSPREY Study for Obstructive Sleep Apnea", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/livanova-demonstrates-84-5-cumulative-145700815.html", "source_name": "Business Wire", "published_at": "2026-06-16T14:57:00+00:00", "published_display": "16 Jun 2026 14:57", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LivaNova (LIVN) Stock Valuation Check After Strong Recent Shareholder Returns", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxPWjF3OWZaa0NXN3IxdU04QnVZQ2c1THRrczRrNTFSQUx4YXE4aXlqM1NVMHJkTVB5QVRlVDM1QktiMHZkRUNVNVFhM1FVYjFYa2ZCUThTZEVocExvQnB3N2xsZGpUYXdkZXB5ejZDb3djbkgtOEJ1NmlwUUhZT1VuSFV4WUFtcE1aWXBBSURZVHRVQlg3ZDYta0hnNlR4SG95TGc?oc=5", "source_name": "Market source", "published_at": "2026-06-12T07:00:00+00:00", "published_display": "12 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Jette Nygaard-Andersen Joins LivaNova Board as a New Director", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/jette-nygaard-andersen-joins-livanova-174400286.html", "source_name": "Business Wire", "published_at": "2026-06-11T17:44:00+00:00", "published_display": "11 Jun 2026 17:44", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LivaNova Stock: My Targets Hold, Maintaining My Rating For 2H26 (NASDAQ:LIVN)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxQMW40ckR6Y0Zuc1BIQnV4UTAwTGdwemNmY3pDSlRkalVfZV9tVTBVQUxKY0VhV3d3LUl5YnQyOTdnX2NZLTZoSklydG50WXlxUkNsLW5wM2F0bGt0ekNMYWZJTzBLVDYzUURRb2Y2bXRCemdzR3E0ZmkxeWRZcGljN1Q2eGhKX1E4T2E3bTFZSngxQjNfZEFXNWVtOUlTa3c3cmJ0QQ?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-06-10T07:00:00+00:00", "published_display": "10 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LivaNova (LIVN) Upgraded to Buy: Here's What You Should Know", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/livanova-livn-upgraded-buy-heres-160006292.html", "source_name": "Zacks", "published_at": "2026-05-11T16:00:06+00:00", "published_display": "11 May 2026 16:00", "sentiment": "positive", "sentiment_pct": 76, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why LivaNova (LIVN) Is Up 18.0% After Boosting 2026 Outlook And Winning Aura6000 FDA Approval", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxPSHRGX3hXUElLelhBcVQ4UkZCNk5XallzbGw5dkJfVktRTmVtamw5V2xwU3dQVUhtc2tmVllPLXlOVkx2VWgta3F5RTd3bVlyZlRaS3RobHlac05rX0RKVl9pbXhyX3l1UzU5WEt1MzlsV2lQYjFIWXhaN3drRlo1Nm9MZEs3RWNyejlkLU16RldyaDlFYkE?oc=5", "source_name": "Market source", "published_at": "2026-05-09T07:00:00+00:00", "published_display": "09 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LivaNova (LIVN) Profit Return And 33.8x P E Test Bullish Narratives", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LivaNova Q1 2026 slides: double-digit growth drives guidance raise", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxNVG9BV0ZMeXZRQllKa3dSby1oZVNHN2NfcnVER2o4QWlISVBGbGNIVUc1RXdPVk9BaTRfQWFLR2JjdC1NTzVOMk9odXgxamhQcHlNZmVmTVItR3JqN1dtRkpXMHJEQnRjVFpydW00UTZMZ1JtYzZqVHR1U2tsMlkwRUVoUXVBY0llNVpleTl3Y2RrNTcxbEtXVHA1cWdMbzFUT3gzVVY1ajZMOGsxYm5ySGNUODNtQWF4SXZoNzh3?oc=5", "source_name": "Investing.com", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LivaNova PLC Q1 2026 Earnings Call Summary", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxPUkVRSzRoVG1Xb2pUcTRfXzFWN29TeWVvM1hIQlRqMFpVQkh3V3pHb0s4S280RE5pLVRGUDg5NmtBbEJrMnRObE5hZWxCLUtvSjdLMmhzSVVXM01rc2pCSEFuWndKMm1JR2xsbkdTUG9kZzFsVG1ocGc2OWZJM0NteDFtZzZkM1hsQ1k3VXVGTHZqVlV3cW9jRWxxSXJ2SHc?oc=5", "source_name": "Market source", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LivaNova (LIVN) Q1 Earnings and Revenues Surpass Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxNTlpqdTZWTHFVQXdZQjBXRGU2Z21ZTTR3cEFfV0RiNkhaeDJGOTUzcUhzdnNPbjBhbjVzWlFXZnMxZURXamhHRF93RHU0TXl2dVZ5a3RKTUhndnFTaDl6THZFZk1uTXIwWmx3ZFBPR0VRMzhXZkw0UTB3Vjh5OFd0MzJWRG1ueG45ZGV2WTRuVWxlZkF0bVRoSFFaWnJwOE1p?oc=5", "source_name": "Market source", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LIVANOVA ($LIVN) Releases Q1 2026 Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxNUXFZVDd0SF9wTFprNjV4TDdNczhKeER2cGU4WTY4cE55VWllWDdNazBjU2NONzVuaFkzc1VkYXdFS19EdEYyVDJpTC01akhkTEFqRFE1MUpHUld1MkEzZ21RQkVvTlhaZVFHS3lhdXEwZ0xMNmxrenZOT1ZCVVdMTVlVNHhuMzl0?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LivaNova (LIVN) Announces FDA Approval of aura6000 System for Obstructive Sleep Apnea", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxONGdvZUgyeXNFVzB1cTc5UzI4V08xcXQ3cFkxUG94dUd0WkFNWjhYWWZxajkzYVdsOEFSYnJ1NTZKS3FEcjZvZ3JjTlRRZVdaSlV1NFpTZGxReFQzNUZMeWhOVEdyLTNWbHNtM0RlSWVYWE9FNmRQWkhyY2VicnBRVHowRVFGZzBzUHBheXhmbHNJLXk4Rk9LM0U4OG1wUDdKbkoxOTk3NFc?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LivaNova\u2019s Aura6000 FDA Win Reshapes Obstructive Sleep Apnea Opportunity", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-03-21T07:00:00+00:00", "published_display": "21 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LivaNova wins FDA Approval for sleep apnea treatment device", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxQXzVkOTAteTBCWF9lUktZTUctSFZlbnJ1ZXZZQXJBN0Fnc0NUaDg0YTJURnJlRVE4a0ZSMmNPejBGWmk1RjFkM0U3RTJOcGZDNUR2Tk9QSE5qNDI4VjF0WHF0X0lqekdQVjB6b1RpQ2lTQlZWd1NfQy1sZkx6RHRfRE1Lb1lFVzRiT3hGVG90UDV1ZDdpWFpqYTducG9nQQ?oc=5", "source_name": "Medical Economics", "published_at": "2026-03-19T07:00:00+00:00", "published_display": "19 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look At LivaNova (LIVN) Valuation After Earnings Show Growth Guidance And A Swing To Net Loss", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxQeXRtV2pzbkM5OE1IbUU3RjdUVXFWNl9qWEo1SGZWMHU5emJ3TXBCckJwYTBHNG8yTUNrREVQMS00Q2Vqbk1uM0d3aHlYb2dFQmRjblZFYnBwRllDelQ3UkEzSTlUcUVINV9NanFmR09keXRuSURvQ2MxUExZLWhfSjB4X2NmSXpLclpr?oc=5", "source_name": "Market source", "published_at": "2026-03-03T08:00:00+00:00", "published_display": "03 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAJBVV95cUxQLWl0NWl5MFJhUXFSN0pzSW1sVzJVb21XVml0X0doQnd5eDVUQmVqeFZWSmNmdlZaV2pfbFk3UEl3RXlqZ05pckozR0dnNHNEUlpTa2FPYWc1Z3Q0Y2tXYTljZUlQRkVZNzY2Sl9yRksyUDJkNVQzSTBuLW9uMnI5bzBfTTJGdDUzd25DN3dDSmhwWnpGVXZRVVM2Uy1zMnp4STZ1RGdZZkRpZ21Pb2xtWjRSTk1kc2JrT28wTG81NDV1M2tWaVdrOXBQdVZSTExiTVEzMXpqRnJWWi0xcEdMYVFILXZXbXZVZl9GRm12aTl5OGk4X1dSVjVyU2FIVFpubk1YNm5fQll0MVZqRTZpTA?oc=5", "source_name": "StockStory", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdFRrRlJvM3J3cGJnVEJ6ZndqMnQxWkE4Wm8zTGtPTVc0OTlLN1pwNXIyclNJMFZkcG5qQTRTWThmNm9WN0hKYXBja3N3Y20zSlkxc2JaQlpYTnAyWnpvUVBvR1JWNmVxZGhSYVlYQklMd01GeFBVNGJWOFBWYUkwYmRrM2xrSktiQWpfTkZtNG1HWThNT0tqLUpYek5qcnFWMGE0QV9CaElrMUpfTEhnOC1pS2t1bkE2VVJHdEhWdEtoX2xKNE1MWk1OSlBSNTVZVU83WEpnb3E4aURwQ3ZyZUFDbndpTTZEa0lZRTJvU2VuTDhreXdCQ25iV3Y4YWxENm1xYQ?oc=5", "source_name": "StockStory", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNMzBPcXU1cnZKekZnaGlNVk05ZWFTWThNOS0tTlpvQjdaLVZIWlVXUk50NnVoQ0pPWWJpZUpWcVJyVDJMd2RJREVDbEEzTlU5UGhBbWtxWVEyVkdaMTVuNXZpaWFMNTZUQ2d0OW9Rc29kalJRY21naWlHZDBLS3RuZV9wdTdIUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 108, "total_relevant": 64, "sentiment_summary": {"positive": 20, "negative": 3, "neutral": 41, "score": 57, "total": 64, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 75, "events": [{"event": "general", "label": "Market update", "weight": 15.2, "count": 27}, {"event": "earnings", "label": "Earnings", "weight": 11.69, "count": 24}, {"event": "analyst", "label": "Analyst action", "weight": 3.45, "count": 5}, {"event": "guidance", "label": "Guidance", "weight": 1.65, "count": 3}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 1.1, "count": 2}, {"event": "liquidity", "label": "Balance sheet", "weight": 0.55, "count": 1}], "positive_events": 20, "negative_events": 3}, "market_context": {"has_market_context": true, "latest_close": 82.56, "latest_week": "2026-07-10", "one_week_move": -1.3, "four_week_move": 4.0, "twelve_week_move": 23.0, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 1.173678, "market_dynamics_buy_signal": false, "relative_strength": 14.882398, "fair_value_gap": 53.3, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "negative", "expectation_probability": 43.9911, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "-1.3% over one week, +4.0% over four weeks, trend active, and materially above fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 65, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 14}, {"label": "TradingView", "count": 11}, {"label": "GuruFocus", "count": 3}, {"label": "Investing.com", "count": 3}, {"label": "simplywall.st", "count": 3}, {"label": "www.marketscreener.com", "count": 3}, {"label": "Business Wire", "count": 3}, {"label": "MSN", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 53}, {"label": "Industry context", "count": 11}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 27}, {"label": "Earnings", "count": 24}, {"label": "Analyst action", "count": 5}, {"label": "Guidance", "count": 3}, {"label": "Regulatory and legal", "count": 2}, {"label": "Balance sheet", "count": 1}, {"label": "Macro sensitivity", "count": 1}, {"label": "Deals and strategy", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "57/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "75/100 classification confidence."}, {"label": "Company focus", "value": "53", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "3", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "-1.3% over one week, +4.0% over four weeks, trend active, and materially above fair value."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "LIVN Maintains by Mizuho -- Price Target Raised to $95.00"}], "updated_at": "2026-07-17T07:50:38.121589+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}